298 results on '"ARAF"'
Search Results
2. ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1
- Author
-
Su, Wenjing, Mukherjee, Radha, Yaeger, Rona, Son, Jieun, Xu, Jianing, Na, Na, Merna Timaul, Neilawattie, Hechtman, Jaclyn, Paroder, Viktoriya, Lin, Mika, Mattar, Marissa, Qiu, Juan, Chang, Qing, Zhao, Huiyong, Zhang, Jonathan, Little, Megan, Adachi, Yuta, Han, Sae-Won, Taylor, Barry S, Ebi, Hiromichi, Abdel-Wahab, Omar, de Stanchina, Elisa, Rudin, Charles M, Jänne, Pasi A, McCormick, Frank, Yao, Zhan, and Rosen, Neal
- Subjects
Cancer ,Rare Diseases ,Lung ,ErbB Receptors ,Guanosine Triphosphate ,Humans ,Neurofibromin 1 ,Protein Binding ,Proto-Oncogene Proteins A-raf ,Signal Transduction ,ras GTPase-Activating Proteins ,ARAF ,ERK signaling ,NF1 ,RAS-GTP ,drug sensitivity ,receptor tyrosine kinase inhibitor ,Biological Sciences ,Medical and Health Sciences ,Developmental Biology - Abstract
RAF protein kinases are effectors of the GTP-bound form of small guanosine triphosphatase RAS and function by phosphorylating MEK. We showed here that the expression of ARAF activated RAS in a kinase-independent manner. Binding of ARAF to RAS displaced the GTPase-activating protein NF1 and antagonized NF1-mediated inhibition of RAS. This reduced ERK-dependent inhibition of RAS and increased RAS-GTP. By this mechanism, ARAF regulated the duration and consequences of RTK-induced RAS activation and supported the RAS output of RTK-dependent tumor cells. In human lung cancers with EGFR mutation, amplification of ARAF was associated with acquired resistance to EGFR inhibitors, which was overcome by combining EGFR inhibitors with an inhibitor of the protein tyrosine phosphatase SHP2 to enhance inhibition of nucleotide exchange and RAS activation.
- Published
- 2022
3. Toxoplasma gondii infection regulates apoptosis of host cells via miR-185/ARAF axis
- Author
-
Dingzeyang Su, Shifan Zhu, Zhaofeng Hou, Fuxing Hao, Kangzhi Xu, Fan Xu, Yuyang Zhu, Dandan Liu, Jinjun Xu, and Jianping Tao
- Subjects
Toxoplasma gondii ,Host cell ,miR-185 ,ARAF ,Apoptosis ,Regulation ,Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Background Toxoplasmosis is a zoonosis with a worldwide presence that is caused by the intracellular parasite Toxoplasma gondii. Active regulation of apoptosis is an important immune mechanism by which host cells resist the growth of T. gondii or avoid excessive pathological damage induced by this parasite. Previous studies found that upregulated expression of microRNA-185 (miR-185) during T. gondii infection has a potential role in regulating the expression of the ARAF gene, which is reported to be associated with cell proliferation and apoptosis. Methods The expression levels of miR-185 and the ARAF gene were evaluated by qPCR and Western blot, respectively, in mice tissues, porcine kidney epithelial cells (PK-15) and porcine alveolar macrophages (3D4/21) following infection with the T. gondii ToxoDB#9 and RH strains. The dual luciferase reporter assay was then used to verify the relationship between miR-185 and ARAF targets in PK-15 cells. PK-15 and 3D4/21 cell lines with stable knockout of the ARAF gene were established by CRISPR, and then the apoptosis rates of the cells following T. gondii infection were detected using cell flow cytometry assays. Simultaneously, the activities of cleaved caspase-3, as a key apoptosis executive protein, were detected by Western blot to evaluate the apoptosis levels of cells. Results Infection with both the T. gondii ToxoDB#9 and RH strains induced an increased expression of miR-185 and a decreased expression of ARAF in mice tissues, PK-15 and 3D4/21 cells. MiR-185 mimic transfections showed a significantly negative correlation in expression levels between miR-185 and the ARAF gene. The dual luciferase reporter assay confirmed that ARAF was a target of miR-185. Functional investigation revealed that T. gondii infection induced the apoptosis of PK-15 and 3D4/21 cells, which could be inhibited by ARAF knockout or overexpression of miR-185. The expression levels of cleaved caspase-3 protein were significantly lower in cells with ARAF knockout than in normal cells, which were consistent with the results of the cell flow cytometry assays. Conclusions Toxoplasma gondii infection could lead to the upregulation of miR-185 and the downregulation of ARAF, which was not related to the strain of T. gondii and the host cells. Toxoplasma gondii infection could regulate the apoptosis of host cells via the miR-185/ARAF axis, which represents an additional strategy used by T. gondii to counteract host-cell apoptosis in order to maintain survival and reproduce in the host cells. Graphical Abstract
- Published
- 2023
- Full Text
- View/download PDF
4. Toxoplasma gondii infection regulates apoptosis of host cells via miR-185/ARAF axis.
- Author
-
Su, Dingzeyang, Zhu, Shifan, Hou, Zhaofeng, Hao, Fuxing, Xu, Kangzhi, Xu, Fan, Zhu, Yuyang, Liu, Dandan, Xu, Jinjun, and Tao, Jianping
- Subjects
TOXOPLASMA gondii ,GENE expression ,MICRORNA ,APOPTOSIS ,ALVEOLAR macrophages ,PORCINE reproductive & respiratory syndrome - Abstract
Background: Toxoplasmosis is a zoonosis with a worldwide presence that is caused by the intracellular parasite Toxoplasma gondii. Active regulation of apoptosis is an important immune mechanism by which host cells resist the growth of T. gondii or avoid excessive pathological damage induced by this parasite. Previous studies found that upregulated expression of microRNA-185 (miR-185) during T. gondii infection has a potential role in regulating the expression of the ARAF gene, which is reported to be associated with cell proliferation and apoptosis. Methods: The expression levels of miR-185 and the ARAF gene were evaluated by qPCR and Western blot, respectively, in mice tissues, porcine kidney epithelial cells (PK-15) and porcine alveolar macrophages (3D4/21) following infection with the T. gondii ToxoDB#9 and RH strains. The dual luciferase reporter assay was then used to verify the relationship between miR-185 and ARAF targets in PK-15 cells. PK-15 and 3D4/21 cell lines with stable knockout of the ARAF gene were established by CRISPR, and then the apoptosis rates of the cells following T. gondii infection were detected using cell flow cytometry assays. Simultaneously, the activities of cleaved caspase-3, as a key apoptosis executive protein, were detected by Western blot to evaluate the apoptosis levels of cells. Results: Infection with both the T. gondii ToxoDB#9 and RH strains induced an increased expression of miR-185 and a decreased expression of ARAF in mice tissues, PK-15 and 3D4/21 cells. MiR-185 mimic transfections showed a significantly negative correlation in expression levels between miR-185 and the ARAF gene. The dual luciferase reporter assay confirmed that ARAF was a target of miR-185. Functional investigation revealed that T. gondii infection induced the apoptosis of PK-15 and 3D4/21 cells, which could be inhibited by ARAF knockout or overexpression of miR-185. The expression levels of cleaved caspase-3 protein were significantly lower in cells with ARAF knockout than in normal cells, which were consistent with the results of the cell flow cytometry assays. Conclusions: Toxoplasma gondii infection could lead to the upregulation of miR-185 and the downregulation of ARAF, which was not related to the strain of T. gondii and the host cells. Toxoplasma gondii infection could regulate the apoptosis of host cells via the miR-185/ARAF axis, which represents an additional strategy used by T. gondii to counteract host-cell apoptosis in order to maintain survival and reproduce in the host cells. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. Feature Extraction and Reduction by using Modified Apriori algorithm.
- Author
-
T., Asha, Vatsa, Pratyush, Kumar, Khushwant, Karmakar, Raj Kumar, M., Sugam Chand, and B. S., Maya
- Subjects
APRIORI algorithm ,ASSOCIATION rule mining ,FEATURE extraction ,BIG data ,FEATURE selection ,WEIGHT lifting ,DATA mining ,MEDIAN (Mathematics) - Abstract
Feature selection is of great importance in the world of data mining. The existing algorithms for doing so lead to extremely high dimensionality when interactions among features are considered. So, an algorithm is needed to extract only useful features. An Improvised approach for association rule mining is devised, which does not require the users to provide support and confidence values and we are considering the interaction among features and relative confidence to get the better result. The user can specify the number of rules and features that have to be generated. This method has an advantage over Standard Apriori, as it gives more control over the efficiency and quality of the results. It is also capable to handle large data sets and high dimensions more effectively. We calculated mean, median, variance and standard deviation on the lift value of rules generated and found that variance of improvised apriori is 30 - 40% lower than that of standard apriori, which indicates that modified Apriori performs better than standard apriori. The mean and median value of the lift is also 20 - 50% higher in modified apriori than in standard apriori, which implies that the features are more tightly coupled in modified apriori than in standard apriori and hence have a higher probability of getting the perfect result. [ABSTRACT FROM AUTHOR]
- Published
- 2023
6. ABL1/2 and DDR1 Drive MEKi Resistance in NRAS-Mutant Melanomas by Stabilizing RAF/MYC/ETS1 and Promoting RAF Homodimerization.
- Author
-
Lyon, Anastasia, Tripathi, Rakshamani, Meeks, Christina, He, Daheng, Wu, Yuanyuan, Liu, Jinpeng, Wang, Chi, Chen, Jing, Zhu, Haining, Mukherjee, Sujata, Ganguly, Saptadwipa, and Plattner, Rina
- Subjects
- *
DRUG repositioning , *GENETIC mutation , *MELANOMA , *ANIMAL experimentation , *ANTINEOPLASTIC agents , *PROTEIN-tyrosine kinase inhibitors , *GENOME-wide association studies , *CELL survival , *PROTEIN-tyrosine kinases , *RESEARCH funding , *DRUG resistance in cancer cells , *MICE , *PHARMACODYNAMICS - Abstract
Simple Summary: NRAS-mutant melanoma is a highly aggressive subtype with few treatment options. Although both BRAF-mutant and NRAS-mutant melanomas have activation of the MEK/ERK pathway, MEK inhibitors (MEKi) are only effective for the BRAF-mutant subtype. The aim of this study was to understand why MEKi are ineffective in NRAS-mutant melanomas with the long-term goal of identifying new treatment regimens. Here, we show that ABL and DDR kinases are critically important for MEKi resistance because they cooperate to promote the stability of key proteins involved in driving melanoma growth and survival. FDA-approved drugs that inhibit ABL1/2 and DDR1 have been used for decades to treat leukemia. We showed that one such inhibitor prevents MEKi resistance from developing in a NRAS-mutant melanoma animal model. Thus, the data in this study provide the rationale for testing the use of drugs targeting ABL1/2 and DDR1 in combination with MEKi for patients with NRAS-mutant melanomas who have failed to respond to immunotherapy. Melanomas harboring NRAS mutations are a particularly aggressive and deadly subtype. If patients cannot tolerate or the melanomas are insensitive to immune checkpoint blockade, there are no effective 2nd-line treatment options. Drugs targeting the RAF/MEK/ERK pathway, which are used for BRAF-mutant melanomas, do little to increase progression-free survival (PFS). Here, using both loss-of-function and gain-of-function approaches, we show that ABL1/2 and DDR1 are critical nodes during NRAS-mutant melanoma intrinsic and acquired MEK inhibitor (MEKi) resistance. In some acquired resistance cells, ABL1/2 and DDR1 cooperate to stabilize RAF proteins, activate ERK cytoplasmic and nuclear signaling, repress p27/KIP1 expression, and drive RAF homodimerization. In contrast, other acquired resistance cells depend solely on ABL1/2 for their survival, and are sensitive to highly specific allosteric ABL1/2 inhibitors, which prevent β-catenin nuclear localization and destabilize MYC and ETS1 in an ERK-independent manner. Significantly, targeting ABL1/2 and DDR1 with an FDA-approved anti-leukemic drug, reverses intrinsic MEKi resistance, delays acquisition of acquired resistance, and doubles the survival time in a NRAS-mutant mouse model. These data indicate that repurposing FDA-approved drugs targeting ABL1/2 and DDR1 may be a novel and effective strategy for treating patients with treatment-refractory NRAS-driven melanomas. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
7. In Vitro and In Vivo Activity of Luliconazole (NND-502) against Planktonic Cells and Biofilms of Azole Resistant Aspergillus fumigatus.
- Author
-
Furnica, Dan-Tiberiu, Dittmer, Silke, Sanders, Maike Isabell, Steinmann, Joerg, Rath, Peter-Michael, and Kirchhoff, Lisa
- Subjects
- *
ASPERGILLUS fumigatus , *MICROBIAL sensitivity tests , *GREATER wax moth , *BIOFILMS , *GENTIAN violet - Abstract
Aspergillus fumigatus has become a significant threat in clinical settings. Cases of invasive infections with azole-resistant A. fumigatus isolates (ARAF) increased recently. Developing strategies for dealing with ARAF has become crucial. We here investigated the in-vitro and in-vivo activity of the imidazole luliconazole (LLCZ) against clinical ARAF. In total, the LLCZ minimum inhibitory concentrations (MICs) were tested for 101 A. fumigatus isolates (84 ARAF and 17 azole-susceptible A. fumigatus as wild-type controls) according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST). Additionally, antifungal activity was assessed in vitro, including an XTT planktonic growth kinetics assay and biofilm assays (crystal violet and XTT assay). Further, a single-dose LLCZ treatment (152 mg/L) was tested for seven days in vivo in a Galleria mellonella infection model. LLCZ showed an MIC50 of 0.002 mg/L and no significant difference was found between triazole-resistant and wild-type isolates. Growth inhibition took place between 6 and 12 h after the start of incubation. LLCZ inhibited biofilm formation when added in the pre-adhesion stages. In vivo, single-dose LLCZ-treated larvae show a significantly higher survival percentage than the control group (20%). In conclusion, LLCZ has activity against planktonic cells and early biofilms of ARAF. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
8. CRAF dimerization with ARAF regulates KRAS-driven tumor growth
- Author
-
Avinashnarayan Venkatanarayan, Jason Liang, Ivana Yen, Frances Shanahan, Benjamin Haley, Lilian Phu, Erik Verschueren, Trent B. Hinkle, David Kan, Ehud Segal, Jason E. Long, Tony Lima, Nicholas P.D. Liau, Jawahar Sudhamsu, Jason Li, Christiaan Klijn, Robert Piskol, Melissa R. Junttila, Andrey S. Shaw, Mark Merchant, Matthew T. Chang, Donald S. Kirkpatrick, and Shiva Malek
- Subjects
KRAS ,CRAF ,BRAF ,ARAF ,MAPK ,MEK ,Biology (General) ,QH301-705.5 - Abstract
Summary: KRAS, which is mutated in ∼30% of all cancers, activates the RAF-MEK-ERK signaling cascade. CRAF is required for growth of KRAS mutant lung tumors, but the requirement for CRAF kinase activity is unknown. Here, we show that subsets of KRAS mutant tumors are dependent on CRAF for growth. Kinase-dead but not dimer-defective CRAF rescues growth inhibition, suggesting that dimerization but not kinase activity is required. Quantitative proteomics demonstrates increased levels of CRAF:ARAF dimers in KRAS mutant cells, and depletion of both CRAF and ARAF rescues the CRAF-loss phenotype. Mechanistically, CRAF depletion causes sustained ERK activation and induction of cell-cycle arrest, while treatment with low-dose MEK or ERK inhibitor rescues the CRAF-loss phenotype. Our studies highlight the role of CRAF in regulating MAPK signal intensity to promote tumorigenesis downstream of mutant KRAS and suggest that disrupting CRAF dimerization or degrading CRAF may have therapeutic benefit.
- Published
- 2022
- Full Text
- View/download PDF
9. Case Report: Early Distant Metastatic Inflammatory Myofibroblastic Tumor Harboring EML4-ALK Fusion Gene: Study of Two Typical Cases and Review of Literature
- Author
-
Qianqian Han, Xin He, Lijuan Cui, Yan Qiu, Yuli Li, Huijiao Chen, and Hongying Zhang
- Subjects
inflammatory myofibroblastic tumor ,early distant metastasis ,EML4-ALK fusion variant 3a/b ,NOTCH1 ,ARAF ,ALK inhibitor ,Medicine (General) ,R5-920 - Abstract
Inflammatory myofibroblastic tumor (IMT) is a distinctive neoplasm that frequently arises in the lung and accounts for ~1% of lung tumors. Distant metastatic IMT is extremely rare and has been poorly investigated. This analysis was specifically performed to explore the clinicopathological and genetic features of early distant metastatic IMT. Two typical patients with distant metastatic IMTs were selected, which accounted for 1.13% of all diagnosed IMTs in the last 5 years. One patient was a 55 year-old male, and the other patient was a 56 year-old female. Both primary tumors arose from the lung, and the initial clinical symptoms of the two patients involved coughing. Both of the imaging examinations showed low-density nodular shadows in the lungs with enhancement around the mass. Microscopically, dense arranged tumor cells, prominent cellular atypia, and high mitotic activity with atypical form were more prominent in the metastatic lesions than in the primary lesions. All of the primary and metastatic tumors in both cases showed positive anaplastic lymphoma kinase (ALK) immunostaining and ALK rearrangement via fluorescence in situ hybridization. The EML4 (exon 6)-ALK (exon 20) fusion variant (v3a/b) was identified by using next-generation sequencing (NGS) and was verified by using reverse transcription polymerase chain reaction (RT-PCR). Furthermore, intronic variants of NOTCH1 and synonymous variants of ARAF were also detected via NGS in one IMT for the first time and were verified in all of the primary and metastatic lesions via PCR. Distant metastasis occurred during a short period of time (1 and 2 months) after the first surgery. One patient presented with multiple metastases to the subcutaneous tissue and bone that responded to ALK inhibitor alectinib therapy, and the tumor was observed to regress 10 months after the initial ALK inhibitor therapy. In contrast, the other patient presented with subcutaneous neck metastasis without ALK inhibitor treatment and succumbed to the disease within 3 months after the surgery. This study demonstrated the possible role of EML4-ALKv3a/b in the malignant progression of IMT and proposed certain therapeutic effects of ALK inhibitors on multiple metastatic IMTs.
- Published
- 2022
- Full Text
- View/download PDF
10. Environmental Hot Spots and Resistance-Associated Application Practices for Azole-Resistant Aspergillus fumigatus, Denmark, 2020-2023.
- Author
-
Arendrup MC, Hare RK, Jørgensen KM, Bollmann UE, Bech TB, Hansen CC, Heick TM, and Jørgensen LN
- Subjects
- Denmark epidemiology, Humans, Aspergillosis epidemiology, Aspergillosis microbiology, Aspergillosis drug therapy, Microbial Sensitivity Tests, Mutation, Fungicides, Industrial pharmacology, Genotype, Aspergillus fumigatus drug effects, Aspergillus fumigatus genetics, Aspergillus fumigatus isolation & purification, Azoles pharmacology, Drug Resistance, Fungal, Antifungal Agents pharmacology
- Abstract
Azole-resistant Aspergillus fumigatus (ARAf) fungi have been found inconsistently in the environment in Denmark since 2010. During 2018-2020, nationwide surveillance of clinical A. fumigatus fungi reported environmental TR
34 /L98H or TR46 /Y121F/T289A resistance mutations in 3.6% of isolates, prompting environmental sampling for ARAf and azole fungicides and investigation for selection of ARAf in field and microcosmos experiments. ARAf was ubiquitous (20% of 366 samples; 16% TR34 /L98H- and 4% TR46 /Y121F/T289A-related mechanisms), constituting 4.2% of 4,538 A. fumigatus isolates. The highest proportions were in flower- and compost-related samples but were not correlated with azole-fungicide application concentrations. Genotyping showed clustering of tandem repeat-related ARAf and overlaps with clinical isolates in Denmark. A. fumigatus fungi grew poorly in the field experiment with no postapplication change in ARAf proportions. However, in microcosmos experiments, a sustained complete (tebuconazole) or partial (prothioconazole) inhibition against wild-type A. fumigatus but not ARAf indicated that, under some conditions, azole fungicides may favor growth of ARAf in soil.- Published
- 2024
- Full Text
- View/download PDF
11. Çokkültürlülük, Kimlik Arayışı ve Arafta Kalmak: Elif Şafak'ın Araf ve Hanif Kureishi'nin The Buddha of Suburbia Romanları.
- Author
-
TÖNGÜR, A. Nejat
- Abstract
Copyright of Journal of Faculty of Letters / Edebiyat Fakultesi Dergisi is the property of Hacettepe University Faculty of Letters and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2021
- Full Text
- View/download PDF
12. The non-linearity of RAF-MEK signaling in dendritic cells.
- Author
-
Riegel, Kristina and Rajalingam, Krishnaraj
- Subjects
DENDRITIC cells ,KINASES ,MITOGEN-activated protein kinases ,IMMUNE response - Abstract
Kinases form the major part of the druggable genome and their selective inhibition in human cancers has had reasonable clinical success. In contrast to tumorigenesis, the role of kinases in mediating immune responses is poorly understood. However, synergistic therapeutic regimens combining targeted therapy and immune therapy have been found to increase the median survival of tumor patients. In this context, we uncovered that RAF and MEK1/2 kinases, which are the integral parts of the classical MAPK cascade, have unique roles in driving DC differentiation and activation. RAF kinases are stabilized in their protein levels during DC differentiation and are obligatory for normal functioning of DCs. But, the targeting of MEK1/2 kinases with specific inhibitors did not phenocopy the effects observed with RAF inhibitors suggesting that RAF and MEK1/2 kinases may have specific and unique roles in driving immune responses, which deserves further studies to successfully administer these inhibitors in clinics. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
13. RAF-MEK-ERK pathway in cancer evolution and treatment
- Author
-
Rahim Ullah, Lixin Wan, Qing Yin, and Aidan H. Snell
- Subjects
Proto-Oncogene Proteins B-raf ,Mitogen-Activated Protein Kinase Kinases ,0301 basic medicine ,MAPK/ERK pathway ,Gene isoform ,Cancer Research ,MAP Kinase Signaling System ,Kinase ,Cell growth ,Cancer ,Biology ,medicine.disease ,Cell biology ,03 medical and health sciences ,Crosstalk (biology) ,030104 developmental biology ,0302 clinical medicine ,Neoplasms ,030220 oncology & carcinogenesis ,medicine ,Humans ,ARAF ,Signal transduction ,Extracellular Signal-Regulated MAP Kinases ,Signal Transduction - Abstract
The RAF-MEK-ERK signaling cascade is a well-characterized MAPK pathway involved in cell proliferation and survival. The three-layered MAPK signaling cascade is initiated upon RTK and RAS activation. Three RAF isoforms ARAF, BRAF and CRAF, and their downstream MEK1/2 and ERK1/2 kinases constitute a coherently orchestrated signaling module that directs a range of physiological functions. Genetic alterations in this pathway are among the most prevalent in human cancers, which consist of numerous hot-spot mutations such as BRAFV600E. Oncogenic mutations in this pathway often override otherwise tightly regulated checkpoints to open the door for uncontrolled cell growth and neoplasia. The crosstalk between the RAF-MEK-ERK axis and other signaling pathways further extends the proliferative potential of this pathway in human cancers. In this review, we summarize the molecular architecture and physiological functions of the RAF-MEK-ERK pathway with emphasis on its dysregulations in human cancers, as well as the efforts made to target the RAF-MEK-ERK module using small molecule inhibitors.
- Published
- 2022
- Full Text
- View/download PDF
14. Spatial regulation of ARAF controls the MST2-Hippo pathway.
- Author
-
Rauch, Jens and Kolch, Walter
- Subjects
- *
SCAFFOLD proteins , *PROTEIN kinases , *EPITHELIAL tumors , *CELL proliferation , *CELL membranes , *RAS oncogenes - Abstract
The RAF-MAPK signaling pathway regulates several very diverse cellular processes such as proliferation, differentiation, apoptosis, and transformation. While the canonical function of RAF kinases within the MAPK pathway is the activation of MEK, our group could demonstrate an important crosstalk between RAF signaling and the pro-apoptotic mammalian sterile 20-like kinase (MST2) tumor suppressor pathway in several cancer entities, including head and neck, colon, and breast. Here, the RAF kinases CRAF and ARAF sequester and inhibit the pro-apoptotic kinase MST2 independently of their own kinase activity. In our recent study, we showed that the ARAF-MST2 complex is regulated by subcellular compartmentalization during epithelial differentiation. Proliferating cells of the basal cell layer in squamous epithelia and tumor cells express ARAF at the mitochondria thus allowing for efficient sequestration of MST2. In contrast, non-malignant squamous epithelia have ARAF localized at the plasma membrane, where the control of MST2-mediated apoptosis is compromised. This re-distribution is regulated by the scaffold protein kinase suppressor of Ras 2 (KSR2). Here, we summarize how spatial and temporal regulation of RAF signaling complexes affect cellular signaling and functions. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
15. Avrupa Resim Sanatında İsa'nın Ölüleri Kurtarması İle İlgili Resimler.
- Author
-
HARMAN, Mürüvet
- Abstract
Copyright of Yedi is the property of YEDI (Dokuz Eylul Universitesi Guzel Sanatlar Fakultesi Yayini) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2019
- Full Text
- View/download PDF
16. Protomer selectivity of type II RAF inhibitors within the RAS/RAF complex.
- Author
-
Vasta, James D., Michaud, Ani, Zimprich, Chad A., Beck, Michael T., Swiatnicki, Matthew R., Zegzouti, Hicham, Thomas, Morgan R., Wilkinson, Jennifer, Crapster, J. Aaron, and Robers, Matthew B.
- Subjects
- *
RAS oncogenes , *BRAF genes , *MITOGEN-activated protein kinases , *ALLELES , *CELL lines - Abstract
RAF dimer inhibitors offer therapeutic potential in RAF- and RAS-driven cancers. The utility of such drugs is predicated on their capacity to occupy both RAF protomers in the RAS-RAF signaling complex. Here we describe a method to conditionally quantify drug-target occupancy at selected RAF protomers within an active RAS-RAF complex in cells. RAF target engagement can be measured in the presence or absence of any mutant KRAS allele, enabling the high-affinity state of RAF dimer inhibitors to be quantified in the cellular milieu. The intracellular protomer selectivity of clinical-stage type II RAF inhibitors revealed that ARAF protomer engagement, but not engagement of BRAF or CRAF, is commensurate with inhibition of MAPK signaling in various mutant RAS cell lines. Our results support a fundamental role for ARAF in mutant RAS signaling and reveal poor ARAF protomer vulnerability for a cohort of RAF inhibitors undergoing clinical evaluation. [Display omitted] • RAF protomer occupancy is quantified within select RAS/RAF complexes using BRET • RAF target engagement is sensitized by KRAS (G12C) and KRAS (G13D) • ARAF, but not BRAF or CRAF engagement, is commensurate with MAPK inhibition • Compared to BRAF and CRAF, clinical-stage drugs escape ARAF inhibition in cells Vasta and coworkers have developed a live-cell method to query engagement of individual RAF protomers in complex with KRAS-GTP. Among the RAF paralogs, only engagement of ARAF was commensurate with MAPK inhibition. This analysis supports a fundamental role for ARAF in mutant KRAS signaling. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
17. Longitudinal change of genetic variations in cetuximab-treated metastatic colorectal cancer
- Author
-
Jeong Eun Kim, Su Han Cho, Tae Won Kim, Sun Young Kim, Eunyoung Tak, Sung-Min Chun, Yong Sang Hong, and Kwoneel Kim
- Subjects
Adult ,Male ,Cancer Research ,Colorectal cancer ,medicine.medical_treatment ,Cetuximab ,Gene mutation ,Targeted therapy ,Antineoplastic Agents, Immunological ,Biomarkers, Tumor ,Genetics ,medicine ,Humans ,Longitudinal Studies ,Neoplasm Metastasis ,neoplasms ,Molecular Biology ,Aged ,biology ,Cancer ,Middle Aged ,Prognosis ,medicine.disease ,digestive system diseases ,Gene Expression Regulation, Neoplastic ,Survival Rate ,Mutation ,Cancer research ,biology.protein ,ERCC2 ,Female ,Cyclin-dependent kinase 6 ,Neoplasm Recurrence, Local ,ARAF ,Colorectal Neoplasms ,Follow-Up Studies ,medicine.drug - Abstract
Recurrent gene mutations and copy number alterations in cancer patients are presumably associated with resistance to targeted therapy. In the present study, we assessed the gene mutations and copy number alterations that recurrently occurred in cetuximab-treated patients with metastatic colorectal cancer (mCRC). Targeted next-generation sequencing was performed in the tumor samples obtained pre- and postcetuximab treatment to assess the variations that occurred during cetuximab treatment. Moreover, we identified the emergent gene mutations (CDK6, EPHA3, ERCC2, MYC, PCMTD1, PIK3CA, PRIM2, RICTOR, and ZNRF3) and copy number alterations (ARAF, BCL2, BRCA2, EGFR, MYC, and SMAD4) that were recurrently observed only in postprogression samples and not in pretreatment or posttreatment samples from patients revealing clinical response. Furthermore, to identify the feasible candidate variations implicated in treatment resistance, we examined the variants with clonal expansion during treatment and discovered PCBP1 as a variant associated with posttreatment progression. Various recurrent mutations were enriched in the TGF-beta signaling pathway. Collectively, we identified recurrent variations in mCRC samples exhibiting post-cetuximab progression. Additionally, future studies are required to evaluate the therapeutic potential of these variations.
- Published
- 2021
- Full Text
- View/download PDF
18. NRAS-driven melanoma: A RAF can hide another
- Author
-
Sabine Druillennec, Celio Pouponnot, and Alain Eychène
- Subjects
araf ,braf ,craf ,ras ,human ,melanoma ,mouse ,resistance ,tumor ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Using mouse genetics, we recently showed that BRAF has a critical role in initiation of NRAS-driven melanoma that cannot be compensated by CRAF. In contrast, RAF proteins display compensatory functions in fully established tumors and ARAF can sustain proliferation in the absence of BRAF and CRAF, highlighting an addiction to RAF signaling in NRAS-driven melanoma.
- Published
- 2017
- Full Text
- View/download PDF
19. Genetic Diversity and Azole Resistance Among Natural Aspergillus fumigatus Populations in Yunnan, China
- Author
-
Jianping Xu, Bin Peng, Ke-Qin Zhang, Ruirui Wang, Guang-Zhu Yang, Xiao Li, Ying Zhang, and Duanyong Zhou
- Subjects
Ecological niche ,Genetic diversity ,Ecology ,biology ,Resistance (ecology) ,Soil Science ,Zoology ,biology.organism_classification ,Aspergillus fumigatus ,Genotype ,Genetic variation ,Biological dispersal ,ARAF ,Ecology, Evolution, Behavior and Systematics - Abstract
The emergence and spread of azole resistance alleles in clinical and environmental isolates of Aspergillus fumigatus is a global human health concern and endangers the "One Health" approach in our fight against antifungal resistance (AFR) in this pathogen. A major challenge to combat AFR in A. fumigatus is the massive aerial dispersal ability of its asexual spores. Our recent fine-scale survey of greenhouse populations of A. fumigatus near Kunming, Yunnan, China, suggested that the use of azole fungicides for plant protection was likely a major driver of the high-frequency azole-resistant A. fumigatus (ARAF) in greenhouses. Here, we investigated the potential spread of those ARAF and the structure of geographic populations of A. fumigatus by analyzing 452 isolates from 19 geographic locations across Yunnan. We found lower frequencies of ARAF in these outdoor populations than those in greenhouses near Kunming, but there were abundant new alleles and new genotypes, including those associated with azole resistance, consistent with multiple independent origins of ARAF across Yunnan. Interestingly, among the four ecological niches, the sediments of a large lake near Kunming were found to have the highest frequency of ARAF (~ 43%). While most genetic variations were observed within the 19 local populations, statistically significant genetic differentiations were found between many subpopulations within Yunnan. Furthermore, similar to greenhouse populations, these outdoor populations of A. fumigatus in Yunnan were significantly different from those in other parts of the world. Our results call for increased attention to local and regional studies of this fungal pathogen to help develop targeted control strategies against ARAF.
- Published
- 2021
- Full Text
- View/download PDF
20. Targeting the p300/NONO axis sensitizes melanoma cells to BRAF inhibitors
- Author
-
Xiaofeng Tang, Xiao-Bin Lv, Jun Sun, Renfeng Liu, Ruihao Zhou, Song Fan, Feifei Zhang, Guofu Huang, Yiping Liang, Cheng Ju, Xia Liu, Zhiping Zhang, Changhua Zhang, Bo Yu, and Tiebang Kang
- Subjects
0301 basic medicine ,Cancer Research ,Mutation ,biology ,Kinase ,Melanoma ,medicine.disease ,medicine.disease_cause ,In vitro ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Ubiquitin ,Downregulation and upregulation ,In vivo ,030220 oncology & carcinogenesis ,Genetics ,biology.protein ,medicine ,Cancer research ,ARAF ,neoplasms ,Molecular Biology - Abstract
BRAF inhibitors (BRAFi) that target BRAF V600E kinase, a driver mutation found in 50% of melanomas, show a significant antitumor response, but the common emergence of acquired resistance remains a challenge. Abnormal expression of RAF isoforms CRAF and ARAF reactivates pERK1/2, which plays crucial roles in the acquisition of resistance of melanoma cells. However, the mechanisms of dysregulation of RAF isoforms in resistant melanoma cells remain unknown. Here, we identified NONO interacted with and stabilized both CRAF and ARAF in melanoma cells, and that NONO was acetylated at 198K by p300 acetyltransferase, which stabilized NONO via antagonizing its ubiquitination/degradation mediated by RNF8. The upregulation of both p300 and NONO promoted the rebound of pERK1/2 and the subsequent resistance of melanoma cells to BRAFi, and the activation of ERK1/2 in turn induced p300 to form a positive feedback loop in resistant melanoma cells. There was a positive correlation between p300 and NONO in resistant melanoma cells and clinical samples, and p300 inhibitor C646 overcame the resistance of resistant melanoma cells to BRAF inhibitors in vitro and in vivo. Our findings reveal that targeting the positive feedback loop of p300-NONO-CRAF/ARAF-pERK1/2 may be excellent strategies to overcome the resistance of BRAF inhibitors for melanoma patients.
- Published
- 2021
- Full Text
- View/download PDF
21. ARAF
- Author
-
Choi, Sangdun, editor
- Published
- 2018
- Full Text
- View/download PDF
22. AKSIOLOGI PEMBELAJARAN S}ARAF DALAM MEMBACA KITAB KUNING
- Author
-
R Ahmad and Hastang Hastang
- Subjects
Data display ,Arabic ,Reading (process) ,media_common.quotation_subject ,Qualitative descriptive ,Mathematics education ,language ,ARAF ,Psychology ,Word (group theory) ,language.human_language ,media_common - Abstract
This research aims to find out how the application of S}araf in reading yellow book using qualitative descriptive research. The subjects of the study were lecturers of science s}araf, lecturers of Qiraah and Mut}alaáh as well as students of Arabic program at IAIN Bone. Data were collected through observation, interview and documentation techniques. Data analysis was carried out in three stages continuously including data reduction, data display and conclusion/verification withdrawal stage. The results shows that S}araf learning materials are divided into three stages; S}araf 1, S}araf2 and S}araf 3 by using various methods, including lecturing, discussions, demontation of bags }rif and tadrib. Tadrib/exercise was carried out with bag exercise }rif, practicing to make sentences, analyzing the function and form of words and giving harakat to a reading. The application of s}araf in reading the yellow book was began by giving harakat to a text to determine its meaning. S}araf, that has a study on the formation of the word is very instrumental in this case. Mastery of the bag will make it easier to read a reading, whether it has harakat or not. The understanding of an Arabic text is not limited to the mastery of any existing mufradat, but rather must pay attention to the form of the word used.
- Published
- 2021
- Full Text
- View/download PDF
23. Use of Synthetic Glycolipids to Probe the Number and Position of Arabinan Chains on Mycobacterial Arabinogalactan
- Author
-
Avraham Liav, Michael R. McNeil, Todd L. Lowary, Shiva K. Angala, Maju Joe, and Mary Jackson
- Subjects
0301 basic medicine ,Spectrometry, Mass, Electrospray Ionization ,Stereochemistry ,Galactans ,01 natural sciences ,Biochemistry ,Article ,Mycobacterium ,Cell wall ,03 medical and health sciences ,chemistry.chemical_compound ,Residue (chemistry) ,Tandem Mass Spectrometry ,Arabinogalactan ,Carbohydrate Conformation ,biology ,010405 organic chemistry ,Mycobacterium smegmatis ,General Medicine ,Galactan ,biology.organism_classification ,0104 chemical sciences ,030104 developmental biology ,Carbohydrate Sequence ,chemistry ,Molecular Probes ,Molecular Medicine ,Peptidoglycan ,Glycolipids ,ARAF ,Bacterial outer membrane ,Chromatography, Liquid - Abstract
The arabinogalactan of Corynebacterianeae is a critical heteropolysaccharide that tethers outer membrane mycolic acids to peptidoglycan thus forming the characteristic cell wall core of these prokaryotes. An essential α-(1→5)-arabinosyltransferase, AftA, is responsible for the transfer of the first arabinofuranosyl (Araf) unit of the arabinan domain to the galactan backbone of arabinogalactan, but the number and precise position at which Araf residue(s) is/are added in mycobacteria remain ill-defined. Using membrane preparations from Mycobacterium smegmatis overexpressing aftA, farnesyl-phospho-arabinose as an Araf donor, and a series of synthetic galactan acceptors of various lengths, we here show that a single priming arabinosyl residue substitutes the C-5 position of a precisely positioned internal 6-linked galactofuranosyl residue of the galactan acceptors, irrespective of their length. This unexpected result suggests that, like the structurally related mycobacterial lipoarabinomannans, the arabinogalactan of mycobacteria may in fact harbor a single arabinan chain.
- Published
- 2020
- Full Text
- View/download PDF
24. LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors
- Author
-
Peter S. Hammerman, Jing Yuan, Lesley A. Mathews Griner, Peter Aspesi, Daniel J. McKay, Gwynn Pardee, Hui Qin Wang, Kelli-Ann Monaco, Ribo Guo, Kenneth Crawford, Stephania Widger, Darrin Stuart, Vesselina G. Cooke, Karen Bui, Felipa A. Mapa, Yuji Mishina, Mariela Jaskelioff, Jeffrey A. Engelman, Paul Fordjour, Emma Labrot, Giordano Caponigro, Stacy Higgins, Jessi Ambrose, John Fuller, Jinsheng Liang, John Green, and Scott Delach
- Subjects
Proto-Oncogene Proteins B-raf ,0301 basic medicine ,Neuroblastoma RAS viral oncogene homolog ,MAPK/ERK pathway ,Cancer Research ,MAP Kinase Signaling System ,Mutant ,medicine.disease_cause ,Proto-Oncogene Proteins p21(ras) ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Neoplasms ,medicine ,Animals ,Humans ,Extracellular Signal-Regulated MAP Kinases ,Protein Kinase Inhibitors ,Kinase ,Chemistry ,Dabrafenib ,HCT116 Cells ,Proto-Oncogene Proteins c-raf ,030104 developmental biology ,Oncology ,Cell culture ,030220 oncology & carcinogenesis ,Mutation ,Cancer research ,Female ,KRAS ,Protein Multimerization ,ARAF ,medicine.drug - Abstract
Purpose: Targeting RAF for antitumor therapy in RAS-mutant tumors holds promise. Herein, we describe in detail novel properties of the type II RAF inhibitor, LXH254. Experimental Design: LXH254 was profiled in biochemical, in vitro, and in vivo assays, including examining the activities of the drug in a large panel of cancer-derived cell lines and a comprehensive set of in vivo models. In addition, activity of LXH254 was assessed in cells where different sets of RAF paralogs were ablated, or that expressed kinase-impaired and dimer-deficient variants of ARAF. Results: We describe an unexpected paralog selectivity of LXH254, which is able to potently inhibit BRAF and CRAF, but has less activity against ARAF. LXH254 was active in models harboring BRAF alterations, including atypical BRAF alterations coexpressed with mutant K/NRAS, and NRAS mutants, but had only modest activity in KRAS mutants. In RAS-mutant lines, loss of ARAF, but not BRAF or CRAF, sensitized cells to LXH254. ARAF-mediated resistance to LXH254 required both kinase function and dimerization. Higher concentrations of LXH254 were required to inhibit signaling in RAS-mutant cells expressing only ARAF relative to BRAF or CRAF. Moreover, specifically in cells expressing only ARAF, LXH254 caused paradoxical activation of MAPK signaling in a manner similar to dabrafenib. Finally, in vivo, LXH254 drove complete regressions of isogenic variants of RAS-mutant cells lacking ARAF expression, while parental lines were only modestly sensitive. Conclusions: LXH254 is a novel RAF inhibitor, which is able to inhibit dimerized BRAF and CRAF, as well as monomeric BRAF, while largely sparing ARAF.
- Published
- 2020
- Full Text
- View/download PDF
25. Alterations of Glucose Uptake and Protein Expression Related to the Insulin Signaling Pathway in the Brain of Phenobarbital-Addictive Rats by 18F-FDG PET/CT and Proteomic Analysis
- Author
-
Liang Liu, Ying Li, Yan Dai, Yue Chen, Guojun Wang, Qingze Fan, Shousong Cao, Bimin Feng, Xiaofeng Pu, and Maolin Wang
- Subjects
medicine.medical_specialty ,business.industry ,Insulin ,medicine.medical_treatment ,Glucose uptake ,General Chemistry ,Metabolism ,Carbohydrate metabolism ,medicine.disease ,Biochemistry ,Endocrinology ,Insulin resistance ,Downregulation and upregulation ,Internal medicine ,medicine ,Phenobarbital ,ARAF ,business ,medicine.drug - Abstract
Drug addiction is a chronic relapsing brain disease. Alterations of glucose uptake and metabolism are found in the brain of drug addicts. Insulin mediates brain glucose metabolism and its abnormality could induce brain injury and cognitive impairment. Here, we established a rat model of phenobarbital addiction by 90 days of dose escalation and evaluated addiction-related symptoms. We also performed 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) to detect glucose uptake in the brain and proteomic analysis of the function of the differentially expressed (DE) proteins via bioinformatics in brain tissues by liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) on days 60 and 90 of phenobarbital or 0.5% carboxymethyl cellulose sodium (CMC-Na) (vehicle) administration. The results showed that phenobarbital-addictive rats developed severe withdrawal symptoms after abstinence and glucose uptake was significantly increased in the brain. Proteomics analysis showed that numerous DE proteins were enriched after phenobarbital administration, among which CALM1, ARAF, and Cbl proteins (related to the insulin signaling pathway) were significantly downregulated on day 60 but not day 90. However, SLC27A3 and NF-κB1 proteins (related to insulin resistance) were significantly upregulated on day 90 (data are available via ProteomeXchange with identifier PXD021101). Our data indicate that the insulin signaling pathway and insulin resistance may play a role in the development of phenobarbital addiction and brain injury, so the findings may have important clinical implications.
- Published
- 2020
- Full Text
- View/download PDF
26. Isolation of azole-resistant Aspergillus fumigatus from imported plant bulbs in Japan and the effect of fungicide treatment
- Author
-
Daisuke Hagiwara
- Subjects
0106 biological sciences ,chemistry.chemical_classification ,Health, Toxicology and Mutagenesis ,Benomyl ,Plant Bulbs ,010501 environmental sciences ,Biology ,Isolation (microbiology) ,biology.organism_classification ,01 natural sciences ,Prochloraz ,Aspergillus fumigatus ,Fungicide ,010602 entomology ,chemistry.chemical_compound ,Horticulture ,nervous system ,chemistry ,Insect Science ,Azole ,ARAF ,0105 earth and related environmental sciences - Abstract
Increasing numbers of azole-resistant Aspergillus fumigatus (ARAf) in the environment have become a global public health issue. We surveyed tulip bulbs that were imported from the Netherlands and found that 6.3-15.8% of bulbs were contaminated by ARAf with a tandem-repeat mutation in the promoter region of the cyp51A gene. We also showed that fungicide treatment of the tulip bulbs by benomyl or prochloraz effectively reduced the rate of isolation. This is the first report demonstrating a method of eliminating human fungal pathogens from plant bulbs.
- Published
- 2020
- Full Text
- View/download PDF
27. Multidrug Resistance and Plasmid Profile of Staphylococcus Aureus and Escherichia Coli Isolated From Patients Attending Urology Clinic, Dalhatu Araf Specialist Hospital (DASH) Lafia, Nasarawa State, Nigeria
- Author
-
Yaaba Yakubu, Joseph Fuh Nfongeh, Abdullahi Sani Ramalan, and Mojisola Christiana Owoseni
- Subjects
Multiple drug resistance ,Plasmid ,business.industry ,Staphylococcus aureus ,Dash ,Urology clinic ,Medicine ,General Medicine ,ARAF ,business ,medicine.disease_cause ,Escherichia coli ,Microbiology - Published
- 2020
- Full Text
- View/download PDF
28. Structural characterization and immunostimulatory activity of polysaccharides from Pyrus sinkiangensis Yu
- Author
-
Jie Bai, Xiaojing Wang, Ayixiaguli Bakasi, Caixia Dong, Kai Zhou, and Hailiqian Taoerdahong
- Subjects
Magnetic Resonance Spectroscopy ,Cell Survival ,02 engineering and technology ,Xylose ,Nitric Oxide ,Polysaccharide ,Methylation ,Biochemistry ,Pyrus ,Gel permeation chromatography ,Mice ,Structure-Activity Relationship ,03 medical and health sciences ,chemistry.chemical_compound ,Polysaccharides ,Structural Biology ,Animals ,Immunologic Factors ,Viability assay ,Molecular Biology ,030304 developmental biology ,chemistry.chemical_classification ,0303 health sciences ,Molecular Structure ,biology ,Plant Extracts ,Chemistry ,General Medicine ,021001 nanoscience & nanotechnology ,biology.organism_classification ,Molecular Weight ,Xyloglucan ,RAW 264.7 Cells ,Pyrus × sinkiangensis ,Cytokines ,Cytokine secretion ,ARAF ,0210 nano-technology - Abstract
Two neutral polysaccharides (PSNP-1, 104.7 kDa; PSNP-2, 24.5 kDa) were isolated from the pulp of Pyrus sinkiangensis Yu. by using the combined techniques of ion-exchange and gel permeation chromatography. According to the IR, NMR spectra, monosaccharide composition, and methylation analyses, PSNP-1 was mainly composed of glucose and xylose residues, which form a typical xyloglucan. PSNP-2 contained an arabinan region composed of 1,5-linked Araf residues, a xyloglucan region that was mainly composed of t-, 1,2-linked Xylp, and 1,4-, 1,4,6-linked Glcp residues. PSNP-1 and PSNP-2 could stimulate the cell viability, NO release, and cytokine secretion (IL-6 and TNF-α) of RAW264.7 macrophages at the adosage of 250 μg/mL. It was suggested that PSNP-1 and PSNP-2 may increase macrophage-mediated immunostimulatory activity.
- Published
- 2020
- Full Text
- View/download PDF
29. BRAF mutation and its inhibitors in sarcoma treatment
- Author
-
Haotian Liu, Xinyue Liu, Jilong Yang, Nahar Nazmun, and Shafat Hassan
- Subjects
Proto-Oncogene Proteins B-raf ,0301 basic medicine ,MAPK/ERK pathway ,Cancer Research ,Mutation rate ,endocrine system diseases ,medicine.medical_treatment ,Review ,Drug resistance ,medicine.disease_cause ,lcsh:RC254-282 ,Proto-Oncogene Mas ,Targeted therapy ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,skin and connective tissue diseases ,Protein Kinase Inhibitors ,neoplasms ,Mutation ,business.industry ,Melanoma ,Clinical Cancer Research ,Sarcoma ,BRAF inhibitors ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,targeted therapy ,medicine.disease ,digestive system diseases ,enzymes and coenzymes (carbohydrates) ,BRAF mutation ,030104 developmental biology ,Oncology ,030220 oncology & carcinogenesis ,Cancer research ,ARAF ,Signal transduction ,business - Abstract
The mitogen‐activated protein kinase (MAPK) signaling pathway plays a significant role in mediating cellular physiological activities, such as proliferation, differentiation, apoptosis, and senescence. This signaling pathway is composed of several major proto‐oncogenes of RAS/RAF/MEK/ERK, among which the BRAF proto‐oncogene, as one of the three members of the RAF family, has a higher mutation rate than ARAF and CRAF and has attracted extensive attention. Regarding the BRAF mutation, approximately 95% of BRAF mutations belong to the BRAF V600E mutation, which can enhance the expression of the MAPK signaling pathway and is thus related to the occurrence and development of various malignant tumors and has been successfully identified as a therapeutic target. Moreover, drug resistance to BRAF inhibitor treatment also appears to be an important issue. Considering the successful use of BRAF inhibitors in melanoma, we provide a brief overview of the BRAF mutations, including their basic structures and activation mechanisms, and the new classification method for BRAF mutations. Most importantly, we summarize the results of BRAF inhibitor treatment in different sarcomas. To overcome drug resistance to BRAF inhibitor treatment, we also outline the different mechanisms of drug resistance to BRAF inhibitor treatment and introduce the combination strategy of BRAF inhibitors with other targeted therapies., BRAF structures and their activation mechanisms.
- Published
- 2020
- Full Text
- View/download PDF
30. Open Surgery for Urinary Stones in a Resource Poor Setting: A Look at Dalhatu Araf Specialist Hospital, Lafia, Nigeria
- Author
-
C. U. Agbo
- Subjects
Resource poor ,medicine.medical_specialty ,business.industry ,General surgery ,Open surgery ,Urinary system ,medicine ,General Earth and Planetary Sciences ,ARAF ,business ,General Environmental Science - Abstract
Urinary stone disease has afflicted humankind since antiquity[1]. It remains a common urological condition worldwide, including in our environment[2]. Although open surgery was previously the main option for stone removal, advances in technology mean that treatment is now largely through minimally invasive surgery, as recommended by a number of urological guidelines[3,4]. Unfortunately, at our centre, we still treat urinary stones solely through open surgery, mostly because we lack endoscopic equipment. In addition, most of our patients, even if referred to facilities where endoscopic management is possible, cannot afford the cost of treatment.
- Published
- 2021
- Full Text
- View/download PDF
31. One year later: The effect of changing azole-treated bulbs for organic tulips bulbs in hospital environment on the azole-resistant Aspergillus fumigatus rate
- Author
-
Gabriel Reboux, Emeline Scherer, Laurence Millon, Steffi Rocchi, Chloé Godeau, Service de parasitologie et mycologie [CHRU de Besançon], Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Laboratoire Chrono-environnement - CNRS - UBFC (UMR 6249) (LCE), Centre National de la Recherche Scientifique (CNRS)-Université de Franche-Comté (UFC), and Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC)
- Subjects
Azoles ,Antifungal ,Antifungal Agents ,Genotype ,medicine.drug_class ,Population ,organic tulips bulbs ,Azole resistance ,Tulipa ,Microbial Sensitivity Tests ,Plant Roots ,hospital environment ,Aspergillus fumigatus ,Fungal Proteins ,03 medical and health sciences ,0302 clinical medicine ,azole resistance ,Drug Resistance, Fungal ,medicine ,030212 general & internal medicine ,education ,TR34/L98H qPCR detection ,[SDV.EE.SANT]Life Sciences [q-bio]/Ecology, environment/Health ,chemistry.chemical_classification ,Organic Agriculture ,0303 health sciences ,education.field_of_study ,biology ,030306 microbiology ,General Medicine ,Plant Bulbs ,biology.organism_classification ,Hospitals ,Horticulture ,Infectious Diseases ,chemistry ,Azole ,ARAF - Abstract
Azole-treated plant bulbs have already been evoked as a potential explanation of the worldwide spread of azole-resistant Aspergillus fumigatus (ARAf). We previously pointed out the presence of a high rate of ARAf (71% of A. fumigatus detected on azole-supplemented media) in flower beds containing azole-treated bulbs at the hospital's surroundings. We show here that planting organic bulbs can be a solution to reduce ARAf burden (from 71% rate to below 3%). The results suggest that replacing treated bulbs with organic bulbs may be sufficient to regain a population that is predominantly susceptible in just 1 year. Lay Summary Antifungal resistance is increasingly observed in fungal pathogens. This study argues that planting organic bulbs in hospitals’ outdoor surroundings could be a good alternative to continue to beautify green spaces, without the risk of dissipating antifungal-resistant fungal pathogens.
- Published
- 2021
- Full Text
- View/download PDF
32. Novel pectin from crude polysaccharide of Syzygium aromaticum against SARS-CoV-2 activities by targeting 3CLpro
- Author
-
Yi Zang, Mei xia Li, Kan Ding, Ya qi Ding, Bo Feng, Yang xiao Ding, Can Jin, Xia Chen, Jia Li, Bo Zhang, Xin wen Chen, Rong juan Pei, Chun fan Huang, and Zhen yun Du
- Subjects
Arabinose ,Glycan ,food.ingredient ,biology ,Pectin ,Rhamnose ,Stereochemistry ,Polysaccharide binding ,chemistry.chemical_compound ,food ,chemistry ,Galactose ,biology.protein ,Glycosyl ,ARAF - Abstract
To date, COVID-19 is still a severe threat to public health, hence specific effective therapeutic drugs development against SARS-CoV-2 is urgent needed. 3CLpro and PLpro and RdRp are the enzymes required for the SARS-CoV-2 RNA synthesis. Therefore, binding to the enzyme may interfere the enzyme function. Before, we found that sulfated polysaccharide binding to 3CLpro might block the virus replication. Hence, we hypothesize that negative charged pectin glycan may also impede the virus replication. Here we show that 922 crude polysaccharide from Syzygium aromaticum may near completely block SARS-CoV-2 replication. The inhibition rate was 99.9% (EC50 : 0.90 μM). Interestingly, 922 can associates with 3CLpro, PLpro and RdRp. We further show that the homogeneous glycan 922211 from 922 may specifically attenuate 3CL protease activity. The IC50s of 922 and 922211 against 3CLpro are 4.73 ± 1.05 µM and 0.18 ± 0.01 µM, respectively. Monosaccharide composition analysis reveals that 922211 with molecular weight of 78.7 kDa is composed of rhamnose, galacturonic acid, galactose and arabinose in the molar ratio of 8.21 : 37.81 : 3.58 : 4.49. The structure characterization demonstrated that 922211 is a homogalacturonan linked to RG-I pectin polysaccharide. The linear homogalacturonan part in the backbone may be partly methyl esterified while RG-I type part bearing 1, 4-linked α-GalpA, 1, 4-linked α-GalpAOMe and 1, 2, 4-linked α-Rhap. There are four branches attached to C-1 or C4 position of Rhamnose glycosyl residues on the backbone. The branches are composed of 1, 3-linked β-Galp, terminal (T)-linked β-Galp, 1, 5-linked α-Araf, T-linked α-Araf, 4-linked α-GalpA and/or 4-linked β-GalpA. The above results suggest that 922 and 922211 might be a potential novel leading compound for anti-SARS-CoV-2 new drug development.
- Published
- 2021
- Full Text
- View/download PDF
33. Effect of the over-dominant expression of proteins on nicotine heterosis via proteomic analysis
- Author
-
Renxiang Liu, Junhao Zhou, Jianhui Teng, Qian Chen, Zejun Mo, Yuanyuan Pu, Zonglin Tian, and Lili Duan
- Subjects
Proteomics ,Nicotine ,Heterosis ,Science ,Biology ,RFC1 ,Article ,Gene Expression Regulation, Plant ,Tobacco ,Hybrid Vigor ,Genetics ,medicine ,Genes, Dominant ,Plant Proteins ,Hybrid ,Multidisciplinary ,Biological techniques ,Nicotinic agonist ,Medicine ,ARAF ,Plant sciences ,Tobacco leaf ,medicine.drug - Abstract
Heterosis is a common biological phenomenon that can be used to optimize yield and quality of crops. Using heterosis breeding, hybrids with suitable nicotine content have been applied to tobacco leaf production. However, the molecular mechanism of the formation of nicotine heterosis has never been explained from the perspective of protein. The DIA proteomics technique was used to compare the differential proteomics of the hybrid Va116 × Basma, showing strong heterosis in nicotine content from its parent lines Va116 and Basma. Proteomics analysis indicated that 65.2% of DEPs showed over-dominant expression patterns, and these DEPs included QS, BBL, GS, ARAF and RFC1 which related to nicotine synthesis. In addition, some DEPs (including GST, ABCE2 and ABCF1 and SLY1) that may be associated with nicotinic transport exhibited significant heterosis over the parental lines. These findings demonstrated that the efficiency of the synthesis and transport of nicotine in hybrids was significantly higher than that in the parent lines, and the accumulation of over-dominant expression proteins may be the cause of heterosis of nicotinic content in hybrids.
- Published
- 2021
- Full Text
- View/download PDF
34. Identification of a prognostic immune-related signature for small cell lung cancer
- Author
-
Jing Liang, Yaping Guan, Huili Chu, Yan Li, Jian Yi, Hui Yu, Xiaolin Liu, Tiantian Gu, Jun Wang, and Qi Xie
- Subjects
Oncology ,Male ,Cancer Research ,medicine.medical_specialty ,Lung Neoplasms ,tumor mutational burden ,Bioinformatics ,medicine.medical_treatment ,Immune system ,Immunophenotyping ,Risk Factors ,Internal medicine ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Lung cancer ,RC254-282 ,Research Articles ,Proportional hazards model ,business.industry ,Gene Expression Profiling ,immune cell infiltration ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Middle Aged ,medicine.disease ,Prognosis ,Small Cell Lung Carcinoma ,Tumor Burden ,Radiation therapy ,Tumor progression ,immune‐related gene ,Mutation ,Female ,small cell lung cancer ,ARAF ,business ,CD8 ,signature ,Research Article - Abstract
Purpose As a subgroup of lung cancer, small cell lung cancer (SCLC) is characterized by a short tumor doubling time, high rates of early occurred distant cancer spread, and poor outcomes. Despite its exquisite sensitivity to chemotherapy and radiotherapy, acquired drug resistance and tumor progression are typical. This study aimed to develop a robust signature based on immune‐related genes to predict the outcome of patients with SCLC. Methods The expression data of 77 SCLC patients from George's cohort were divided into training set and testing set, and 1534 immune‐related genes from ImmPort database were used to generate and validate the signature. Cox proportional hazards and the Kaplan–Meier analysis were used for developing and testing the prognostic signature. Single‐sample gene set enrichment analysis was used to determine immune cell infiltration phenotypes. Results A 10‐gene model comprising NR3C1, NR1D2, TANK, ARAF, HDGF, INHBE, LRSAM1, PLXNA1, PML, and SP1 with the highest frequency after 1000 interactions, was chosen to construct immune‐related signature. This signature showed robust predictive value for SCLC patients’ survival in both training and testing sets. This signature was weakly associated with the clinic pathological values like TNM stage. Furthermore, patients with low risk presented with activation of immune signal pathways, and specific immune cell infiltration with high levels of CD56bright NK cells but low levels of CD8+ T cells, mast cells, and helper T cells. Conclusion The present study developed immune‐related signature that may help predict the prognosis of SCLC patients, which reflects an unappreciated level of heterogeneity of immunophenotype associated with diverse prognosis for specific subsets in this highly lethal cancer type., Here, we constructed a prognostic immune‐related signature for predicting small cell lung cancer (SCLC) patients’ survival. The 10‐gene signature was enriched in growth factor activity and immune‐related TGF‐β signaling pathway. Furthermore, increased CD56dim NK cells and reduced plasmacytoid dendritic cells infiltration were significantly associated with survival prolongment. However, SCLC patients with low risk presents more CD56bright NK cells but less CD8+ T cells, mast cells, and helper T cells infiltration compared to those with high risk. Our findings indicate that this immune‐related signature may help predict the prognosis of SCLC patients, which reflects an unappreciated level of heterogeneity of immunophenotype associated with diverse prognosis for specific subsets in this highly lethal cancer type.
- Published
- 2021
35. Functional analysis of GT61 glycosyltransferases from grass species in xylan substitutions
- Author
-
Zheng-Hua Ye, Dongtao Cui, Dennis Phillips, Ruiqin Zhong, and Nathanael T. Sims
- Subjects
animal structures ,Mutant ,Arabidopsis ,macromolecular substances ,Plant Science ,Cell wall ,chemistry.chemical_compound ,Cell Wall ,Glycosyltransferase ,Genetics ,Hemicellulose ,biology ,Arabidopsis Proteins ,technology, industry, and agriculture ,food and beverages ,Glycosyltransferases ,biology.organism_classification ,Xylan ,carbohydrates (lipids) ,Biochemistry ,chemistry ,biology.protein ,Brachypodium ,Xylans ,ARAF - Abstract
Multiple rice GT61 members were demonstrated to be xylan arabinosyltransferases (XATs) mediating 3-O-arabinosylation of xylan and the functions of XATs and xylan 2-O-xylosyltransferases were shown to be conserved in grass species. Xylan is the major hemicellulose in the cell walls of grass species and it is typified by having arabinofuranosyl (Araf) substitutions. In this report, we demonstrated that four previously uncharacterized, Golgi-localized glycosyltransferases residing in clade A or B of the rice GT61 family were able to mediate 3-O-arabinosylation of xylan when heterologously expressed in the Arabidopsis gux1/2/3 triple mutant. Biochemical characterization of their recombinant proteins established that they were xylan arabinosyltransferases (XATs) capable of transferring Araf residues onto xylohexaose acceptors, and thus they were named OsXAT4, OsXAT5, OsXAT6 and OsXAT7. OsXAT5 and the previously identified OsXAT2 were shown to be able to arabinosylate xylooligomers with a degree of polymerization of as low as 3. Furthermore, a number of XAT homologs from maize, sorghum, Brachypodium and switchgrass were found to exhibit activities catalyzing Araf transfer onto xylohexaose, indicating that they are XATs involved in xylan arabinosylation in these grass species. Moreover, we revealed that homologs of another GT61 member, xylan 2-O-xylosyltransferase (XYXT1), from these grass species could mediate 2-O-xylosylation of xylan when expressed in the Arabidopsis gux1/2/3 mutant. Together, our findings indicate that multiple OsXATs are involved in 3-O-arabinosylation of xylan and the functions of XATs and XYXTs are conserved in grass species.
- Published
- 2021
36. Aorto-Right Atrial Fistula after Minimally Invasive Tricuspid Valve Repair: A Report of Two Cases
- Author
-
Naohiro Wakabayashi, Hiroyuki Kamiya, Kouhei Ishidou, and Aina Hirofuji
- Subjects
medicine.medical_specialty ,minimally invasive cardiac surgery ,Fistula ,lcsh:Surgery ,tricuspid valve repair ,030204 cardiovascular system & hematology ,Right atrial ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Minimally invasive cardiac surgery ,030212 general & internal medicine ,cardiovascular diseases ,TRICUSPID VALVE REPAIR ,Sinus (anatomy) ,business.industry ,Case Report: Cardiac ,lcsh:RD1-811 ,Commissure ,medicine.disease ,Surgery ,medicine.anatomical_structure ,cardiovascular system ,aorto-right atrial fistula ,Cusp (anatomy) ,ARAF ,business - Abstract
We experienced two cases of postoperative iatrogenic aorto-right atrial fistula (ARAF) after tricuspid valve repair (TVR) using minimally invasive cardiac surgery (MICS) technique. In both the cases, the flow of ARAF passed through the sinus of Valsalva near the noncoronary cusp (NCC)/right coronary cusp (RCC) commissure or NCC to right atrium. The quality of the fine needle used in the MICS technique may be inferior to that used in conventional surgery; ARAF after TVR could be a unique pitfall with the MICS technique.
- Published
- 2020
37. Characterization of Kinase Expression Related to Increased Migration of PC-3M Cells Using Global Comparative Phosphoproteome Analysis
- Author
-
Sangkyu Lee, Tae Gyun Kwon, Yun-Sok Ha, Yan Gao, Jun Nyung Lee, and Young-Chang Cho
- Subjects
Male ,Proteomics ,Cancer Research ,MAP2K2 ,Biology ,Proto-Oncogene Mas ,Biochemistry ,Prostate cancer ,Cell Movement ,Cell Line, Tumor ,Genetics ,medicine ,Humans ,Neoplasm Invasiveness ,Phosphorylation ,Molecular Biology ,Kinase ,Prostate ,Prostatic Neoplasms ,Cancer ,Phosphoproteins ,medicine.disease ,Up-Regulation ,Gene Expression Regulation, Neoplastic ,Disease Progression ,Cancer research ,ARAF ,Signal transduction ,Protein Kinases ,Research Article ,Signal Transduction - Abstract
Background/aim Prostate cancer (PCa) is the second-most commonly occurring cancer among men, worldwide. Although the mechanisms associated with the progression of castration-resistant prostate cancer (CRPC) have been widely studied, the mechanism associated with more distant metastases from the bone remains unknown. This study aimed to characterize potential pathogenic kinases associated with highly metastatic PCa, that may regulate phosphorylation in extensively involved and diverse signaling pathways that are associated with the development of various cancers. Materials and methods A mass spectrometry (MS)-based comparative phosphoproteome strategy was utilized to identify differentially expressed kinases between the highly aggressive PCa cell-lines PC-3 and PC-3M. Results Among 2,968 phosphorylation sites in PCa cells, 151 differently expressed phosphoproteins were identified. Seven motifs: -SP-, -SxxE-, -PxS-, -PxSP-, -SxxK-, -SPxK-, and -SxxxxxP- were found to be highly expressed in PC-3M cells. Based on these motifs, the kinases p21-activated kinase (PAK)2, Ste20-like kinase (SLK), mammalian Ste20-like kinase (MST)4, mitogen-activated kinase kinase (MAP2K)2, and A-Raf proto-oncogene serine/threonine kinase (ARAF) were up-regulated in PC-3M cells. Conclusion PAK2, SLK, MST4, MAP2K2, and ARAF are kinases that are potentially associated with the progression of increased migration in PC-3M cells and may represent molecule regulators or drug targets for highly metastatic PCa therapy.
- Published
- 2020
- Full Text
- View/download PDF
38. A novel small-molecule inhibitor of trefoil factor 3 (TFF3) potentiates MEK1/2 inhibition in lung adenocarcinoma
- Author
-
Mengyi Zhang, Qing-Yun Chong, Alan Prem Kumar, Lingzhi Wang, Peter E. Lobie, Boon Cher Goh, Tao Zhu, Lan Ma, Zhinan Yin, Ru-Mei Chen, Zhengsheng Wu, Baocheng Wang, Yanxin Wang, Zhirong Guo, Basappa, and Vijay Pandey
- Subjects
0301 basic medicine ,Cancer Research ,Matrigel ,Cell growth ,Chemistry ,Trefoil factor 3 ,Cell migration ,medicine.disease ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,lcsh:RC254-282 ,Article ,body regions ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Downregulation and upregulation ,Cancer stem cell ,030220 oncology & carcinogenesis ,Target identification ,medicine ,Cancer research ,Adenocarcinoma ,ARAF ,Molecular Biology ,Non-small-cell lung cancer - Abstract
TFF3 has been identified as a novel biomarker to distinguish between lung adenocarcinoma (ADC) and lung squamous-cell carcinoma (SCC). Herein, we determined the oncogenic functions of TFF3 and demonstrated the potential of pharmacological inhibition of TFF3 in lung ADC using a novel small-molecule inhibitor of TFF3 dimerization (AMPC). Forced expression of TFF3 in lung ADC cells enhanced cell proliferation and survival, increased anchorage-independent growth, cancer stem cell behavior, growth in 3D Matrigel, and cell migration and invasion. In contrast, depleted expression of TFF3 suppressed these cellular functions. Mechanistically, TFF3 exerted its oncogenic function through upregulation of ARAF and hence enhanced downstream activation of MEK1/2 and ERK1/2. Pharmacological inhibition of TFF3 by AMPC, resulted in markedly decreased cell survival, proliferation, 3D growth and foci formation, and impaired tumor growth in a xenograft mouse model. Moreover, the combination of various MEK1/2 inhibitors with AMPC exhibited synergistic inhibitory effects on lung ADC cell growth. In conclusion, this study provides the first evidence that TFF3 is a potent promoter of lung ADC progression. Targeting TFF3 with a novel small-molecule inhibitor alone or in combination with conventional MEK1/2 inhibitors are potential strategies to improve the outcome of lung ADC.
- Published
- 2019
- Full Text
- View/download PDF
39. Dysregulated mitogen-activated protein kinase pathway mediated cell cycle disruption in sporadic parathyroid tumors
- Author
-
Ashutosh Kumar Arya, Sudhaker D Rao, Sanjay Kumar Bhadada, Naresh Sachdeva, Divya Dahiya, Preet Mohinder Singh, A Behera, and Uma Nahar Saikia
- Subjects
Adenoma ,Adult ,Male ,MAPK/ERK pathway ,MAP Kinase Signaling System ,Endocrinology, Diabetes and Metabolism ,MAPK8 ,030209 endocrinology & metabolism ,Biology ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Endocrinology ,medicine ,Humans ,E2F1 ,HRAS ,Parathyroid adenoma ,Gene Expression Profiling ,Cell Cycle ,Middle Aged ,Cell cycle ,medicine.disease ,Parathyroid Neoplasms ,030220 oncology & carcinogenesis ,Cancer research ,Female ,ARAF - Abstract
The study was designed to evaluate expression profiling of mitogen-activated protein kinase (MAPK) signalling pathway genes in sporadic parathyroid adenoma. Expression of MAPK signalling pathway genes including activated transcription factors and cell cycle regulatory genes was analysed by real-time PCR- based array in parathyroid adenoma (N = 20) and normal parathyroid tissue (N = 4). MAPK signalling pathway as studied by PCR array revealed that a total of 22 genes were differentially expressed (≥ twofold change, p ≤ 0.05) in parathyroid adenoma. Up-regulated genes were ARAF, MAPK12, CREBBP, MYC, HSPB1, HRAS, CDK4, CCND1, and E2F1, and down-regulated genes were MAP4K1, DLK1, MAP3K4, MAPK10, MAPK8, ATF2, SMAD4, MEF2C, LAMTOR3, FOS, CDKN2A CDKN2B, and RB1. The present study revealed that ERK1/2 signalling pathway with up-regulation of HRAS, ARAF, and MEK1 genes and up-regulation of positive regulators of cell cycle (CCND1, CDK4, and E2F1) and down-regulation negative regulators of cell cycle (CDKN2A, CDKN2B, and RB1) made highly dysregulated MAPK signalling pathway in parathyroid adenoma. Expression of CDK4 was positively associated with plasma PTH level (r = 0.60, p = 0.04) and tumor weight (r = 0.80, p = 0.02) of the adenoma patients, respectively. Expression of CDKN2A was correlated negatively with PTH level (r = − 0.52, p = 0.04) of the adenoma patients. The current study revealed that ERK pathway and associated cell cycle regulator genes are dysregulated in sporadic parathyroid adenoma.
- Published
- 2019
- Full Text
- View/download PDF
40. Assessment of antiherpetic activity of nonsulfated and sulfated polysaccharides from Azadirachta indica
- Author
-
Jussevania Pereira Santos, Nayara Lopes, Imran Ali, Samantha Fernandes Espada, Ligia Carla Faccin-Galhardi, Rosa Elisa Carvalho Linhares, Carlos Nozawa, Bimalendu Ray, and Sayani Ray
- Subjects
Viral protein ,Herpesvirus 1, Human ,02 engineering and technology ,Virus Replication ,Polysaccharide ,medicine.disease_cause ,Antiviral Agents ,Biochemistry ,Structure-Activity Relationship ,03 medical and health sciences ,Sulfation ,Polysaccharides ,Structural Biology ,Cell Line, Tumor ,medicine ,Humans ,Molecular Biology ,030304 developmental biology ,chemistry.chemical_classification ,0303 health sciences ,Azadirachta ,Molecular mass ,biology ,Sulfates ,Chemistry ,General Medicine ,021001 nanoscience & nanotechnology ,biology.organism_classification ,Mechanism of action ,Nucleic acid ,medicine.symptom ,ARAF ,0210 nano-technology - Abstract
Azadirachta indica leaf is used by Indian population for the healing of various diseases including viral infection. Herein, we analyzed the antiherpetic (HSV-1) activity of two polysaccharides (P1 and P2) isolated from the leaf of A. indica and their chemically sulfated derivatives (P1S and P2S). The molecular weights of P1S and P2S are 41 and 11 kDa, respectively. Sulfate groups are located at positions C3 of the Araf and C6 of both Galp and Glcp residues of the most active polysaccharide (P1S). These compounds were not cytotoxic in HEp-2 cells, up to 1000 μg/mL. Both P1S and P2S exhibited antiviral activity when used simultaneously to HSV-1, with 50% inhibitory concentration/selectivity index, respectively, of 31.1 μg/mL/>51.4 and 80.5 μg/mL/>19.8. P1S showed better inhibitory effect (91.8%) compared to P1 (50%), P2 (71.1%) and P2S (70%) at 200 μg/mL. Synthesis of viral protein showed a dose–dependent response and the nucleic acid synthesis was inhibited up to 25 μg/mL, by P1 and P1S and up to 50 μg/mL, by P2 and P2S. The antiviral effect is probably due to the interference of polysaccharides at the early stages of HSV-1 replication, including adsorption. Further studies are under way to get insight into the mechanism of action of the substances.
- Published
- 2019
- Full Text
- View/download PDF
41. A polysaccharide found in Dendrobium nobile Lindl stimulates calcium signaling pathway and enhances tobacco defense against TMV
- Author
-
Deyu Hu, Jing Shi, Baoan Song, and Zhurui Li
- Subjects
Proteomics ,02 engineering and technology ,Polysaccharide ,Antiviral Agents ,Biochemistry ,Dendrobium nobile ,03 medical and health sciences ,Gene Expression Regulation, Plant ,Polysaccharides ,Structural Biology ,In vivo ,Tombusviridae ,Tobacco ,Tobacco mosaic virus ,Calcium Signaling ,Molecular Biology ,030304 developmental biology ,chemistry.chemical_classification ,0303 health sciences ,biology ,GalP ,Monosaccharides ,General Medicine ,021001 nanoscience & nanotechnology ,biology.organism_classification ,Elicitor ,Molecular Weight ,Enzyme ,chemistry ,biology.protein ,ARAF ,Dendrobium ,0210 nano-technology - Abstract
A neutral polysaccharide separated from Dendrobium nobile Lindl was designated as DNPE6(4). It was structurally characterized using a combination of spectral and chemical analysis. Its average molecule weight was 99.2 kDa. The monosaccharide composition was Araf, Glcp, Galp, and Manp in a molar ratio of 2.5:0.9:0.3:0.8. Their linkage types were →1)-L-Araf-(3→, →1)-D-Glcp-(4→, →1)-D-Galp-(3→, →1)-D-Galp-(6→, →1)-D-Manp-(3, 6→, and T-D-Manp. The polysaccharide was found to have anti-TMV and anti-CMV activities for the first time in vivo. Notably, DNPE6(4) exhibited excellent protective activity against TMV. Furthermore, several proteins related to calcium signaling pathway and pathogen related proteins were up-regulated, and we also found expression levels of EDS1, ICS1, and PR1 involved in SA pathway up-regulated after DNPE6(4) treatment. In addition, some defense enzymes increased in the same condition. All these findings revealed DNPE6(4) was an elicitor to stimulate calcium signaling pathway to enhance the tobacco defense against TMV. This study therefore revealed that DNPE6(4) was a promising antiviral agent for future study.
- Published
- 2019
- Full Text
- View/download PDF
42. ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor
- Author
-
Patricia J. Hicks, Leticia S. Matsuoka, Michael E. March, Matthew R. Swift, Charlly Kao, Mark R Battig, Alvaro Gutierrez-Uzquiza, Christoph Seiler, Hyun Min Jung, Michael A. Levine, Elizabeth J. Bhoj, Courtney N Kaminski, Hakon Hakonarson, Lifeng Tian, Brant M. Weinstein, Yoav Dori, Rosetta M. Chiavacci, Janet T. Strausbaugh, Nora Robinson, Jonathan A. Perkins, Dong Li, Erin Pinto, Tiancheng Wang, Patrick M. A. Sleiman, Jean B. Belasco, Tara L. Wenger, and Yichuan Liu
- Subjects
0301 basic medicine ,Proband ,Trametinib ,Lymphatic edema ,Mutation ,business.industry ,MEK inhibitor ,General Medicine ,medicine.disease ,medicine.disease_cause ,General Biochemistry, Genetics and Molecular Biology ,Lymphatic disease ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Lymphatic system ,030220 oncology & carcinogenesis ,Cancer research ,medicine ,ARAF ,business - Abstract
The treatment of lymphatic anomaly, a rare devastating disease spectrum of mostly unknown etiologies, depends on the patient manifestations1. Identifying the causal genes will allow for developing affordable therapies in keeping with precision medicine implementation2. Here we identified a recurrent gain-of-function ARAF mutation (c.640T>C:p.S214P) in a 12-year-old boy with advanced anomalous lymphatic disease unresponsive to conventional sirolimus therapy and in another, unrelated, adult patient. The mutation led to loss of a conserved phosphorylation site. Cells transduced with ARAF-S214P showed elevated ERK1/2 activity, enhanced lymphangiogenic capacity, and disassembly of actin skeleton and VE-cadherin junctions, which were rescued using the MEK inhibitor trametinib. The functional relevance of the mutation was also validated by recreating a lymphatic phenotype in a zebrafish model, with rescue of the anomalous phenotype using a MEK inhibitor. Subsequent therapy of the lead proband with a MEK inhibitor led to dramatic clinical improvement, with remodeling of the patient's lymphatic system with resolution of the lymphatic edema, marked improvement in his pulmonary function tests, cessation of supplemental oxygen requirements and near normalization of daily activities. Our results provide a representative demonstration of how knowledge of genetic classification and mechanistic understanding guides biologically based medical treatments, which in our instance was life-saving.
- Published
- 2019
- Full Text
- View/download PDF
43. Structural characterization of three polysaccharides from the roots of Codonopsis pilosula and their immunomodulatory effects on RAW264.7 macrophages
- Author
-
Yong-Sheng Cui, Qi-Li Sun, Yi-Xuan Li, Juan Du, Caixia Dong, and Si-Liang Jiang
- Subjects
Rhamnose ,Stereochemistry ,02 engineering and technology ,Polysaccharide ,Methylation ,Plant Roots ,Biochemistry ,Immunomodulation ,Mice ,Structure-Activity Relationship ,03 medical and health sciences ,chemistry.chemical_compound ,Polysaccharides ,Structural Biology ,Arabinogalactan ,Side chain ,Animals ,Molecular Biology ,030304 developmental biology ,chemistry.chemical_classification ,Codonopsis ,0303 health sciences ,Molecular mass ,biology ,Plant Extracts ,GalP ,Codonopsis pilosula ,Macrophages ,Spectrum Analysis ,General Medicine ,021001 nanoscience & nanotechnology ,biology.organism_classification ,Molecular Weight ,RAW 264.7 Cells ,chemistry ,biology.protein ,ARAF ,0210 nano-technology - Abstract
Three polysaccharides were isolated from the roots of Codonopsis pilosula by ion-exchange and gel-filtration chromatography. They were named RCNP, RCAP-1, and RCAP-2, and had apparent molecular weights of 1.14 × 104, 5.09 × 104, and 2.58 × 105, respectively. Their structures were characterized by HPGPC, chemical derivative analysis, GC–MS and NMR analyses. Results showed that RCNP contained arabinan and arabinogalactan regions. The arabinan region had a main chain comprising (1 → 5)-linked Araf residues, and the side chains branched at the O-3 position by the single Araf residues. The arabinogalactan region comprised alternating (1 → 4)-, (1 → 6)- or (1 → 3)-linked Galp along with small amounts of branches mainly at the O-3 position of the (1 → 6)-linked Galp or O-6 position of the (1 → 3)-linked Galp residues by terminally linked Araf residues. RCAP-1 and RCAP-2 were highly methyl-esterified pectin-type polysaccharides with long homogalacturonan regions interrupted by a short rhamnogalacturonan I (RG-I) region. The side chains of the RG-I region consisted of (1 → 2)-linked Rha residues attached to the position O-4 of rhamnose. Their degrees of methyl-esterification were approximately 60.6% and 68.1%, respectively. Bioactivity tests showed that RCAP-1 and RCAP-2 exerted a significant immunostimulatory effect based on NO production from RAW264.7 macrophages. These results suggested that these two pectin-type polysaccharides were potential immunostimulation agents.
- Published
- 2019
- Full Text
- View/download PDF
44. High airborne level of Aspergillus fumigatus and presence of azole-resistant TR34/L98H isolates in the home of a cystic fibrosis patient harbouring chronic colonisation with azole-resistant H285Y A. fumigatus
- Author
-
E. Hecquet, Emilie Fréalle, A. Prévotat, A. Deschildre, M. Paluch, S. Lejeune, Laboratoire de Parasitologie-Mycologie (LPM), IFR 53, Université de Reims Champagne-Ardenne (URCA)-Université de Reims Champagne-Ardenne (URCA)-CHU Maison Blanche-UPRES EA 2070, Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 (CIIL), Centre National de la Recherche Scientifique (CNRS)-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Université de Lille-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Pneumologie et allergologie pédiatriques [CHU Jeanne de Flandre, Lille], Hôpital Jeanne de Flandre [Lille], Centre de Recherche en Chimie Moléculaire (CRCM), Université Sciences et Technologies - Bordeaux 1-Centre National de la Recherche Scientifique (CNRS), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Centre National de la Recherche Scientifique (CNRS), and Université Sciences et Technologies - Bordeaux 1 (UB)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
0301 basic medicine ,Pulmonary and Respiratory Medicine ,A fumigatus ,[SDV]Life Sciences [q-bio] ,Aspergillosis ,Cystic fibrosis ,Aspergillus fumigatus ,Microbiology ,03 medical and health sciences ,0302 clinical medicine ,medicine ,chemistry.chemical_classification ,biology ,business.industry ,Environmental exposure ,biology.organism_classification ,medicine.disease ,3. Good health ,Colonisation ,030104 developmental biology ,030228 respiratory system ,chemistry ,Pediatrics, Perinatology and Child Health ,Azole ,ARAF ,business - Abstract
Azole-resistant Aspergillus fumigatus (ARAF) has been reported in the domestic environment of patients at risk for aspergillosis. Here, we assessed the mother's and father's homes of an 18-year-old cystic fibrosis patient harbouring chronic colonisation with H285Y CYP51A azole-resistant isolate, in order to explore the link between environmental exposure and ARAF infection. In one dwelling, a very high overall contamination level was found (710–7.240 CFU/m3), with a predominance of A. fumigatus (640–6.490 CFU/m3), and ARAF showing the TR34/L98H mutation was isolated. Mycological follow-up of the patient showed the persistence of H285Y isolates, but no acquisition of TR34/L98H isolates was observed. This could be due to the low proportion of TR34/L98H isolates (
- Published
- 2019
- Full Text
- View/download PDF
45. Arabinogalactan-proteins in spore-producing land plants
- Author
-
Jon Utermoehlen, Birgit Classen, and Alexander Baumann
- Subjects
Spores ,Polymers and Plastics ,02 engineering and technology ,010402 general chemistry ,01 natural sciences ,Cell wall ,Mucoproteins ,Arabinogalactan ,Botany ,Materials Chemistry ,Plant Proteins ,Arabinogalactan protein ,biology ,Chemistry ,GalP ,fungi ,Organic Chemistry ,food and beverages ,021001 nanoscience & nanotechnology ,0104 chemical sciences ,Spore ,Yariv reagent ,biology.protein ,Embryophyta ,Bryophyte ,ARAF ,0210 nano-technology - Abstract
Arabinogalactan-proteins (AGPs) are proteoglycans of the extracellular matrix of plants that were first isolated and described in the 1970s. Today, the consensus is that the following features are regarded as typical for these molecules: • a large carbohydrate part of arabinogalactans (approximately around 90% of the molecule), that consists mainly of 3-, 6- and 3,6-linked β- d -Galp residues, substituted with α- l -Araf residues • a small protein moiety mostly rich in hydroxyproline • the ability to precipitate with Yariv phenylglycosides, e.g. the β-glucosyl Yariv reagent In contrast to broad knowledge on AGPs in seed plants, insight in occurrence and structure of AGPs in spore-producing land plants (bryophytes, lycophytes and monilophytes) is very limited, although these plants are the closest living relatives to seed plants. In general, understanding of cell wall evolution is incomplete due to limited knowledge of cell wall structure of non-flowering plants. In this review, current knowledge on AGPs of mosses, clubmosses and ferns is summarized, possible functions are discussed and suggestions for future investigations are given.
- Published
- 2019
- Full Text
- View/download PDF
46. An acidic polysaccharide from Ziziphus Jujuba cv. Muzao: Purification and structural characterization
- Author
-
Xiaolong Ji, Rui Zhang, Fang Liu, Min Wang, Fan Zhang, and Qiang Peng
- Subjects
Arabinose ,Magnetic Resonance Spectroscopy ,Rhamnose ,Microscopy, Atomic Force ,Polysaccharide ,01 natural sciences ,Gas Chromatography-Mass Spectrometry ,Analytical Chemistry ,chemistry.chemical_compound ,0404 agricultural biotechnology ,food ,Polysaccharides ,Spectroscopy, Fourier Transform Infrared ,chemistry.chemical_classification ,Chromatography ,biology ,GalP ,Hexuronic Acids ,010401 analytical chemistry ,Galactose ,Ziziphus ,Glycosidic bond ,04 agricultural and veterinary sciences ,General Medicine ,Nuclear magnetic resonance spectroscopy ,Chromatography, Ion Exchange ,040401 food science ,food.food ,0104 chemical sciences ,Molecular Weight ,chemistry ,Ziziphus jujuba ,Fruit ,biology.protein ,ARAF ,Food Science - Abstract
A novel acidic polysaccharide fraction (PZMP2-2) was isolated from Ziziphus Jujuba cv. Muzao fruit via hot water extraction and purified by DEAE-Sepharose FF and Sephacryl S-300 column chromatography. PZMP2-2 consisted of rhamnose, arabinose, xylose, galactose, and galacturonic acid in a ratio of 1.18: 5.23: 0.22: 2.68: 2.20, with a molecular weight of 62.73 kDa. Structural features of PZMP2-2 were investigated using FT-IR, SEM, AFM, GC–MS analysis and NMR spectroscopy. Methylation and GC–MS analysis revealed that the main glycosidic bonds in PZMP2-2 comprised 1-linked Galp, 1,3-linked Araf, 1,2,4-linked Rhap, 1,3-linked Galp, 1,4-linked GalpA and 1,3,5-linked Araf. NMR analysis indicate that PZMP 2–2 has a linear backbone of (1 → 4)-linked GlcpA and (1 → 2,4)-linked Rhap residues, with branches at the O-4 position, consisting of Araf and Galp residues.
- Published
- 2019
- Full Text
- View/download PDF
47. Immune enhancement activity of a novel polysaccharide produced by Dendrobium officinale endophytic fungus Fusarium solani DO7
- Author
-
Wang Hongfeng, Ying-Jie Zeng, Wen-Yong Lou, Min-Hua Zong, and Hui-Rong Yang
- Subjects
0301 basic medicine ,Medicine (miscellaneous) ,Polysaccharide ,Microbiology ,03 medical and health sciences ,0404 agricultural biotechnology ,Immune system ,Fusarium solani DO7 ,Functional food ,TX341-641 ,chemistry.chemical_classification ,030109 nutrition & dietetics ,Nutrition and Dietetics ,biology ,GalP ,Chemistry ,Nutrition. Foods and food supply ,Dendrobium officinale ,Structure ,04 agricultural and veterinary sciences ,Immune enhancement activity ,biology.organism_classification ,040401 food science ,Embryonic stem cell ,Toxicity ,biology.protein ,ARAF ,Fusarium solani ,Food Science - Abstract
A novel polysaccharide DG2 was obtained from the Dendrobium officinale endophytic fungus Fusarium solani DO7. The structural characterization and immunological activity of DG2 were investigated. Results showed that DG2 with the molecular weight of 152.8 kDa was composed of Galp, Manp, Glcp and Araf at a molar ratio of 4.3:1.9:2.8: 1.0. The main linkage types of DG2 were (1 → )-β-D-Glc, (1 → 4)-β-D-Glc, (1 → 3,6)-β-D-Gal and (1 → 6)-β-D-Gal, which demonstrated DG2 was a novel galactoglucan and different from other fungal and botanic polysaccharide. Furthermore, DG2 did not contain deoxynivalenol, and showed no direct toxicity to human embryonic kidney cells and RAW 264.7 cells. Meanwhile, DG2 could increase the TNF-α, IL-6 and iNOs mRNA expression levels of RAW264.7 cells, and further promote the production of TNF-α, IL-6 and NO. These results suggested DG2 could enhance macrophage-mediated immune responses and have the potential to be an attractive functional food supplement candidate for the hypoimmunity therapies.
- Published
- 2019
48. Structural characterization and intestinal protection activity of polysaccharides from Sea buckthorn (Hippophae rhamnoides L.) berries
- Author
-
Chen Shen, Bin Wang, Zefeng Zhang, Teng Wang, Zhao Yuqin, Sun Kunlai, Xing Zhang, Feng Guo, Yin Chen, and Jie Wang
- Subjects
chemistry.chemical_classification ,Arabinose ,Aging ,Polymers and Plastics ,biology ,Glutathione peroxidase ,Organic Chemistry ,Hippophae rhamnoides ,Polysaccharide ,biology.organism_classification ,Antioxidants ,Superoxide dismutase ,chemistry.chemical_compound ,Drosophila melanogaster ,chemistry ,Catalase ,Polysaccharides ,Galactose ,Hippophae ,Materials Chemistry ,biology.protein ,Animals ,Food science ,ARAF - Abstract
The sea buckthorn (Hippophae rhamnoides L.) berries are rich in various bioactive components and widely used as fruit and traditional medicine. In this study, a novel heteropolysaccharide fraction (SP0.1-1) was isolated from Sea buckthorn berries. SP0.1-1 is composed of mannose, glucose, galactose, and arabinose in the molar ratio of 1:2.3:1.9:11.2 with a core structure containing 1,4-linked-α- d -Glcp, 1,4,6-linked-α- d -Glcp and 1,4-linked-α- d -Manp residues as the backbone. And the side-chains comprised of 1,3,5-linked-α- l -Araf, 1,5-linked-α- l -Araf, terminal α-Araf and 1,4-linked-β- d -Galp. Furthermore, a diet supplemented with SP0.1-1 extended the mean lifespan, enhanced antioxidant enzyme (superoxide dismutase, SOD; glutathione peroxidase, GSH-Px; and catalase, CAT) activities, and decreased the malondialdehyde (MDA) level and hydrogen peroxide (H2O2)-induced mortality rate in fruit flies (Drosophila melanogaster). To summarize, the study's findings will provide evidence for the development of sea buckthorn polysaccharide products.
- Published
- 2021
49. A longitudinal study investigating patient acquisition of azole resistant Aspergillus fumigatus (ARAf)
- Author
-
Amelie P Brackin and Anand Shah
- Subjects
chemistry.chemical_classification ,Longitudinal study ,biology ,chemistry ,Azole ,ARAF ,biology.organism_classification ,Aspergillus fumigatus ,Microbiology - Published
- 2021
- Full Text
- View/download PDF
50. Structural characterization of novel arabinoxylan and galactoarabinan from citron with potential antitumor and immunostimulatory activities
- Author
-
Chun-Yan Shen, Xu Chang, and Jian-Guo Jiang
- Subjects
Arabinose ,Citrus ,Polymers and Plastics ,Stereochemistry ,Mannose ,Nitric Oxide Synthase Type II ,Antineoplastic Agents ,02 engineering and technology ,Xylose ,010402 general chemistry ,Polysaccharide ,01 natural sciences ,Galactans ,chemistry.chemical_compound ,Mice ,Column chromatography ,Cell Line, Tumor ,Arabinoxylan ,Materials Chemistry ,Animals ,Humans ,Immunologic Factors ,Cell Proliferation ,chemistry.chemical_classification ,Interleukin-6 ,Tumor Necrosis Factor-alpha ,Organic Chemistry ,021001 nanoscience & nanotechnology ,0104 chemical sciences ,Molecular Weight ,RAW 264.7 Cells ,chemistry ,Carbohydrate Sequence ,Galactose ,Xylans ,ARAF ,0210 nano-technology - Abstract
This study aimed to extract polysaccharides from citron and analyze their structures and potential bioactivities. Two novel polysaccharides CM-1 and CM-2 were purified from citron by DEAE-Sepharose Fast Flow and Sephadex G-100 column chromatography. Monosaccharide composition, linkage and NMR data were used to infer their sugar chains composition. The anti-breast cancer cells and immunoregulatory activities of CM-1 and CM-2 were investigated. Results indicated that CM-1 (Mw = 21,520 Da), composed of arabinose, xylose, mannose and glucose in a molar ratio of 10.78:11.53:1.00:1.70, was arabinoxylan (AX) with (1 → 4)-linked β- d -Xylp skeleton monosubstituted with α- l -Araf units at O-3 position. While CM-2 (Mw = 22,303 Da), composed of arabinose, mannose, glucose and galactose in a molar ratio of 25.46:1.45:1.00:6.57, was galactoarabinan (GA) with (1 → 5)-linked α- l -Araf backbone substituted by β- d -Galp units at O-2 and/or O-3 positions. Both polysaccharides exhibited potential inhibiting cancer and immunostimulatory activities in vitro, especially CM-1. These results provide a basis for further research on citron polysaccharides.
- Published
- 2021
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.